APA
Katanyoo K., Chitapanarux I., Tungkasamit T., Chakrabandhu S., Chongthanakorn M., Jiratrachu R., Kridakara A., Townamchai K., Muangwong P., Tovanabutra C. & Chomprasert K. (2018). Cost-utility analysis of 5-fluorouracil and capecitabine for adjuvant treatment in locally advanced rectal cancer. : Journal of gastrointestinal oncology.
Chicago
Katanyoo Kanyarat, Chitapanarux Imjai, Tungkasamit Tharatorn, Chakrabandhu Somvilai, Chongthanakorn Marisa, Jiratrachu Rungarun, Kridakara Apiradee, Townamchai Kanokpis, Muangwong Pooriwat, Tovanabutra Chokaew and Chomprasert Kittisak. 2018. Cost-utility analysis of 5-fluorouracil and capecitabine for adjuvant treatment in locally advanced rectal cancer. : Journal of gastrointestinal oncology.
Harvard
Katanyoo K., Chitapanarux I., Tungkasamit T., Chakrabandhu S., Chongthanakorn M., Jiratrachu R., Kridakara A., Townamchai K., Muangwong P., Tovanabutra C. and Chomprasert K. (2018). Cost-utility analysis of 5-fluorouracil and capecitabine for adjuvant treatment in locally advanced rectal cancer. : Journal of gastrointestinal oncology.
MLA
Katanyoo Kanyarat, Chitapanarux Imjai, Tungkasamit Tharatorn, Chakrabandhu Somvilai, Chongthanakorn Marisa, Jiratrachu Rungarun, Kridakara Apiradee, Townamchai Kanokpis, Muangwong Pooriwat, Tovanabutra Chokaew and Chomprasert Kittisak. Cost-utility analysis of 5-fluorouracil and capecitabine for adjuvant treatment in locally advanced rectal cancer. : Journal of gastrointestinal oncology. 2018.